| P50 | author | George Perry | Q5543353 |
| P2093 | author name string | Juan Pedro Luna-Arias | |
| | María Luisa Labra-Barrios | |
| | Raúl Mena | |
| | Sofía Díaz-Cintra | |
| | Claudia Luna-Herrera | |
| | José Luna-Muñoz | |
| | Samadhi Moreno-Campuzano | |
| | Azucena Ruth Aguilar-Vázquez | |
| | Paola Flores-Rodríguez | |
| | Benjamín Florán-Garduño | |
| | Miguel Ángel Ontiveros-Torres | |
| P2860 | cites work | Pro-inflammatory interleukin-18 increases Alzheimer's disease-associated amyloid-β production in human neuron-like cells | Q21245229 |
| | Inflammasome components NALP 1 and 3 show distinct but separate expression profiles in human tissues suggesting a site-specific role in the inflammatory response | Q24336216 |
| | Regulated phosphorylation and dephosphorylation of tau protein: effects on microtubule interaction, intracellular trafficking and neurodegeneration | Q24530141 |
| | Selective inhibition of Alzheimer disease-like tau aggregation by phenothiazines | Q24598853 |
| | Mechanisms of protein seeding in neurodegenerative diseases | Q26994962 |
| | The genetics of Alzheimer disease | Q27026166 |
| | Single-cell imaging of inflammatory caspase dimerization reveals differential recruitment to inflammasomes. | Q27330148 |
| | Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease | Q27860795 |
| | Beta-amyloid stimulation of inducible nitric-oxide synthase in astrocytes is interleukin-1beta- and tumor necrosis factor-alpha (TNFalpha)-dependent, and involves a TNFalpha receptor-associated factor- and NFkappaB-inducing kinase-dependent signalin | Q28564853 |
| | Fe65 is required for Tip60-directed histone H4 acetylation at DNA strand breaks | Q28575987 |
| | Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction | Q29547778 |
| | Cyclin-dependent kinases: engines, clocks, and microprocessors | Q29614786 |
| | The NALP3 inflammasome is involved in the innate immune response to amyloid-beta | Q29615595 |
| | Inflammatory mechanisms in obesity | Q29617932 |
| | A central role for JNK in obesity and insulin resistance | Q29619778 |
| | TLR2 is a primary receptor for Alzheimer's amyloid β peptide to trigger neuroinflammatory activation | Q30176406 |
| | Beta-amyloid-induced glial expression of both pro- and anti-inflammatory cytokines in cerebral cortex of aged transgenic Tg2576 mice with Alzheimer plaque pathology | Q30658083 |
| | Identification of soluble CD14 as an endogenous agonist for Toll-like receptor 2 on human astrocytes by genome-scale functional screening of glial cell derived proteins | Q33268319 |
| | Detailed immunohistochemical characterization of temporal and spatial progression of Alzheimer's disease-related pathologies in male triple-transgenic mice | Q33359744 |
| | Chronic nicotine administration exacerbates tau pathology in a transgenic model of Alzheimer's disease | Q33863598 |
| | Genetic influences on brain structure | Q33955853 |
| | The inflammasome: first line of the immune response to cell stress | Q33998873 |
| | Interleukin-18 alters protein expressions of neurodegenerative diseases-linked proteins in human SH-SY5Y neuron-like cells | Q34014666 |
| | 2012 Alzheimer's disease facts and figures | Q34260109 |
| | Signal transduction by tumor necrosis factor and its relatives | Q34341941 |
| | Activation and signaling of the p38 MAP kinase pathway | Q34390191 |
| | TLR4 mutation reduces microglial activation, increases Aβ deposits and exacerbates cognitive deficits in a mouse model of Alzheimer's disease | Q35203740 |
| | Non-aggregating tau phosphorylation by cyclin-dependent kinase 5 contributes to motor neuron degeneration in spinal muscular atrophy. | Q35423634 |
| | Secreted beta-amyloid precursor protein stimulates mitogen-activated protein kinase and enhances tau phosphorylation. | Q35616076 |
| | Astrocytes Are Primed by Chronic Neurodegeneration to Produce Exaggerated Chemokine and Cell Infiltration Responses to Acute Stimulation with the Cytokines IL-1β and TNF-α. | Q35675181 |
| | The neuropsychological profile of Alzheimer disease | Q35852983 |
| | An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer's disease- associated Aβ oligomers | Q35858008 |
| | Post-translational modifications of tau protein in Alzheimer's disease | Q35934376 |
| | Retinol-binding protein 4 inhibits insulin signaling in adipocytes by inducing proinflammatory cytokines in macrophages through a c-Jun N-terminal kinase- and toll-like receptor 4-dependent and retinol-independent mechanism | Q35943971 |
| | Tau phosphorylation: physiological and pathological consequences | Q35992168 |
| | Activation of Cdk5/p25 and tau phosphorylation following chronic brain hypoperfusion in rats involves microRNA-195 down-regulation | Q48105635 |
| | Astrocytes: conductors of the Alzheimer disease neuroinflammatory symphony | Q48337623 |
| | Glycogen synthase kinase-3 and the Alzheimer-like state of microtubule-associated protein tau. | Q48394153 |
| | Glycogen synthase kinase-3 induces Alzheimer's disease-like phosphorylation of tau: generation of paired helical filament epitopes and neuronal localisation of the kinase | Q48406074 |
| | Oligomers of β-amyloid protein (Aβ1-42) induce the activation of cyclooxygenase-2 in astrocytes via an interaction with interleukin-1β, tumour necrosis factor-α, and a nuclear factor κ-B mechanism in the rat brain. | Q48498357 |
| | REST/NRSF-induced changes of ChAT protein expression in the neocortex and hippocampus of the 3xTg-AD mouse model for Alzheimer's disease | Q48510848 |
| | Plasma cytokines profile in older subjects with late onset Alzheimer's disease or vascular dementia. | Q51919320 |
| | Potentiation of GSK-3-catalyzed Alzheimer-like phosphorylation of human tau by cdk5. | Q52196473 |
| | The complex of microglial cells and amyloid star in three-dimensional reconstruction. | Q52243683 |
| | Proline-directed and non-proline-directed phosphorylation of PHF-tau. | Q53203171 |
| | Staging the pathological assembly of truncated tau protein into paired helical filaments in Alzheimer's disease. | Q53213177 |
| | Conformational change as one of the earliest alterations of tau in Alzheimer's disease. | Q53238045 |
| | Activation of the JNK/p38 pathway occurs in diseases characterized by tau protein pathology and is related to tau phosphorylation but not to apoptosis. | Q53245764 |
| | Phosphorylation Sites on Tau Identified by Nanoelectrospray Mass Spectrometry | Q55919559 |
| | Identification of genes that function in the TNF-alpha-mediated apoptotic pathway using randomized hybrid ribozyme libraries | Q56765488 |
| | Tau protein isoforms, phosphorylation and role in neurodegenerative disorders11These authors contributed equally to this work | Q57897029 |
| | Alzheimer's disease beta-secretase BACE1 is not a neuron-specific enzyme | Q36016766 |
| | A reversible early oxidized redox state that precedes macromolecular ROS damage in aging nontransgenic and 3xTg-AD mouse neurons | Q36037588 |
| | Current advances on different kinases involved in tau phosphorylation, and implications in Alzheimer's disease and tauopathies | Q36174549 |
| | Islet-brain (IB)/JNK-interacting proteins (JIPs): future targets for the treatment of neurodegenerative diseases? | Q36268409 |
| | Contribution of inflammatory processes to Alzheimer's disease: molecular mechanisms | Q36394129 |
| | Deregulated Cdk5 activity is involved in inducing Alzheimer's disease | Q36494716 |
| | Toll-like receptor 4-dependent upregulation of cytokines in a transgenic mouse model of Alzheimer's disease | Q36726269 |
| | JNK pathway: diseases and therapeutic potential | Q36794020 |
| | An update of animal models of Alzheimer disease with a reevaluation of plaque depositions | Q36976873 |
| | TNF-mediated inflammatory disease. | Q37045764 |
| | Stretch-induced regulation of angiotensinogen gene expression in cardiac myocytes and fibroblasts: opposing roles of JNK1/2 and p38alpha MAP kinases | Q37103505 |
| | Microtubule-associated protein tau in development, degeneration and protection of neurons | Q37151485 |
| | Neuropathology and cognitive impairment in Alzheimer disease: a complex but coherent relationship | Q37218110 |
| | Dynamics of the microglial/amyloid interaction indicate a role in plaque maintenance | Q37352312 |
| | The role of scaffold proteins in JNK signalling | Q37634610 |
| | The NLRP3 inflammasome in health and disease: the good, the bad and the ugly | Q37901519 |
| | Exploring the function of the JNK (c-Jun N-terminal kinase) signalling pathway in physiological and pathological processes to design novel therapeutic strategies | Q37977169 |
| | Aβ toxicity in Alzheimer's disease | Q37993451 |
| | Molecular mechanisms of amyloid oligomers toxicity | Q38005284 |
| | Structural biology of presenilins and signal peptide peptidases | Q38098975 |
| | Nuclear and cytosolic JNK signalling in neurons | Q38205111 |
| | Gene expression profiling of amyloid beta peptide-stimulated human post-mortem brain microglia | Q38293592 |
| | The JNK are important for development and survival of macrophages | Q38316183 |
| | Aβ-induced Ca(2+) influx regulates astrocytic BACE1 expression via calcineurin/NFAT4 signals | Q39305720 |
| | Interleukin-18 increases expression of kinases involved in tau phosphorylation in SH-SY5Y neuroblastoma cells | Q39926124 |
| | Role of the toll-like receptor 4 in neuroinflammation in Alzheimer's disease. | Q40056685 |
| | Beta-site APP cleaving enzyme up-regulation induced by 4-hydroxynonenal is mediated by stress-activated protein kinases pathways. | Q40469104 |
| | Tau phosphorylation at serine 396 and serine 404 by human recombinant tau protein kinase II inhibits tau's ability to promote microtubule assembly | Q40878824 |
| | Microglia activation: one of the checkpoints in the CNS inflammation caused by Angiostrongylus cantonensis infection in rodent model | Q41206209 |
| | Alz-50 and MC-1, a new monoclonal antibody raised to paired helical filaments, recognize conformational epitopes on recombinant tau. | Q42654706 |
| | Selective small-molecule inhibitors of glycogen synthase kinase-3 activity protect primary neurones from death | Q43560460 |
| | Paradoxical phosphorylation of the serine 199 on tau proteins from young individuals. | Q43801492 |
| | Prediction of dementia in MCI patients based on core diagnostic markers for Alzheimer disease | Q44619067 |
| | Role of tumor necrosis factor receptor-1 in the death of retinal ganglion cells following optic nerve crush injury in mice | Q44707518 |
| | TNF-α mediates PKR-dependent memory impairment and brain IRS-1 inhibition induced by Alzheimer's β-amyloid oligomers in mice and monkeys. | Q45374664 |
| | Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer's disease. | Q46018632 |
| | c-Jun controls the efficiency of MAP kinase signaling by transcriptional repression of MAP kinase phosphatases | Q46540555 |
| | Deficits in odor-guided behaviors in the transgenic 3xTg-AD female mouse model of Alzheimer׳s disease. | Q47768548 |
| | Propranolol reduces cognitive deficits, amyloid and tau pathology in Alzheimer's transgenic mice | Q48009532 |
| | Inhibition of tau phosphorylating protein kinase cdk5 prevents beta-amyloid-induced neuronal death | Q48087625 |
| | Expression of interleukin-18 is increased in the brains of Alzheimer's disease patients | Q48093126 |
| P433 | issue | 1 | |
| P304 | page(s) | 243-269 | |
| P577 | publication date | 2016-03-22 | |
| P1433 | published in | Journal of Alzheimer's Disease | Q6294755 |
| P1476 | title | Fibrillar Amyloid-β Accumulation Triggers an Inflammatory Mechanism Leading to Hyperphosphorylation of the Carboxyl-Terminal End of Tau Polypeptide in the Hippocampal Formation of the 3×Tg-AD Transgenic Mouse. | |
| P478 | volume | 52 | |